The National Center for Chronic Disease Prevention and Health Promotion, part of the Centers for Disease Control and Prevention (CDC), awarded a $1,500,000 Cooperative Agreement (CFDA 93.135 - Centers for Research and Demonstration for Health Promotion and Disease Prevention) to the University of Alabama at Birmingham (UAB) to implement an AI-based glaucoma screening program within Federally Qualified Health Centers. This 5-year award (9/30/2024 - 9/29/2029) will support UAB in designing,...
The National Eye Institute (NEI) awarded a $425,000 Project Grant (CFDA 93.867 Vision Research) to the Massachusetts Eye and Ear Infirmary to develop a rapid, culture-independent diagnostic approach for detecting pathogens and antimicrobial resistance in sight-threatening ocular infections. The project aims to combine metagenomic sequencing using portable Nanopore technology with novel bioinformatic tools to enable real-time pathogen identification and antimicrobial resistance prediction from...
This Cooperative Agreement award of $500,000.00 from the National Center for Chronic Disease Prevention and Health Promotion (part of the Centers for Disease Control and Prevention) supports the establishment of a Coordinating Center for Sight Studies. The Center will evaluate the effectiveness of telehealth-based programs to detect glaucoma among high-risk populations in community health settings. This 5-year project, which began on September 30, 2024, is funded under the Centers for Research...
The University of Michigan was awarded a $1,500,000 Cooperative Agreement by the Centers for Disease Control and Prevention (CDC) under the "Centers for Research and Demonstration for Health Promotion and Disease Prevention" program (CFDA 93.135). The award, titled "Michigan Screening and Intervention for Glaucoma and Eye Health through Telemedicine (MI-SIGHT) Program: A Pragmatic Randomized Trial", will fund a 5-year project to develop and evaluate a telemedicine-based...
This National Eye Institute (NEI) Project Grant award (CFDA 93.867 - Vision Research) for $715,098 aims to enhance glaucoma risk prediction through advanced genomics and machine learning techniques. The key products and services to be delivered under this 5-year project include: Improving polygenic risk score (PRS) performance for glaucoma by leveraging enhanced electronic health record (EHR) data phenotyping using natural language processing (NLP) on over 68,000 patient records across two...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,477,500 Project Grant to The Schepens Eye Research Institute, Inc., a non-profit organization affiliated with Harvard Medical School and Massachusetts Eye and Ear. The 3-year grant, awarded on September 1, 2023, will fund research on "Topical Calcitonin Gene-Related Peptide for Corneal Injury Prevention and Regeneration." The Schepens Eye Research Institute, which has...
This $241,500 Project Grant award from the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867) will evaluate the impact of patient, neighborhood, and community characteristics on screening and monitoring adherence for diabetic retinopathy (DR) among Medicare beneficiaries with diabetes. The study aims to 1) identify factors associated with adherence to recommended DR screening intervals, and 2) identify factors associated with adherence to recommended DR...
The National Eye Institute (NEI) awarded a $1,448,874 Cooperative Agreement grant under the Vision Research program (CFDA 93.867) to The Regents of the University of California, San Francisco (UCSF) to extend the Village-Integrated Eye Worker Trial II (VIEW II) study. The goal of this 5-year extension project is to determine if a community-based eye disease screening intervention can effectively prevent vision loss in Nepal over a 7-year period. The screening involves using optical coherence...
This National Eye Institute (NEI) Project Grant award under the Vision Research federal grant program (CFDA 93.867) provides $277,197 to Boston Children's Hospital to investigate the social determinants of health contributing to disparities in vision outcomes for children with amblyopia (lazy eye) from historically marginalized communities. The 5-year project aims to leverage large datasets to: Identify modifiable factors influencing access to vision screening and eye specialty care that may...
The Department of Defense's Defense Health Agency awarded a $820,833 Project Grant to The Schepens Eye Research Institute, Inc., a non-profit research organization affiliated with Harvard Medical School and Massachusetts Eye and Ear. The grant, funded through the Military Medical Research and Development program (CFDA 12.420), supports a research project to "Identify the Liver Microenvironment that Drives Uveal Melanoma Metastasis and Immunity." The 3-year award, effective from...